Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cormedix Inc (CRMD)

Cormedix Inc (CRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 832,891
  • Shares Outstanding, K 67,825
  • Annual Sales, $ 43,470 K
  • Annual Income, $ -17,930 K
  • EBIT $ 14 M
  • EBITDA $ 15 M
  • 60-Month Beta 1.54
  • Price/Sales 18.24
  • Price/Cash Flow N/A
  • Price/Book 6.90

Options Overview Details

View History
  • Implied Volatility 64.08% ( -2.71%)
  • Historical Volatility 77.23%
  • IV Percentile 12%
  • IV Rank 19.85%
  • IV High 180.81% on 07/08/24
  • IV Low 35.17% on 10/03/24
  • Put/Call Vol Ratio 0.23
  • Today's Volume 2,870
  • Volume Avg (30-Day) 3,025
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 59,349
  • Open Int (30-Day) 50,246

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 0.15
  • Number of Estimates 2
  • High Estimate 0.16
  • Low Estimate 0.14
  • Prior Year -0.25
  • Growth Rate Est. (year over year) +160.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.39 +66.17%
on 04/17/25
12.33 -0.41%
on 05/16/25
+4.76 (+63.30%)
since 04/16/25
3-Month
5.60 +119.29%
on 04/07/25
12.33 -0.41%
on 05/16/25
+1.80 (+17.18%)
since 02/14/25
52-Week
3.61 +240.17%
on 08/13/24
13.85 -11.34%
on 10/29/24
+7.08 (+136.15%)
since 05/16/24

Most Recent Stories

More News
CorMedix Inc. to Participate in the RBC Global Healthcare Conference

CRMD : 12.28 (+5.05%)
CorMedix: Q1 Earnings Snapshot

CorMedix: Q1 Earnings Snapshot

CRMD : 12.28 (+5.05%)
CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

CRMD : 12.28 (+5.05%)
CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025

CRMD : 12.28 (+5.05%)
CorMedix Stock Rises After Preliminary Q1 Results Exceeds Expectations: Retail’s Elated

The company expects quarterly adjusted earnings before interest, taxes, depreciation, and amortisation (EBITDA) to exceed $22.5 million once final numbers are reported, exceeding expectations of $14.78...

CRMD : 12.28 (+5.05%)
VTI : 292.58 (+0.68%)
IWM : 209.85 (+0.83%)
Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance

CRMD : 12.28 (+5.05%)
CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

CRMD : 12.28 (+5.05%)
CorMedix (CRMD) Q4 2024 Earnings Call Transcript

CRMD earnings call for the period ending December 31, 2024.

CRMD : 12.28 (+5.05%)
CorMedix Stock Loses Almost A Third Of Its Market Cap After Downbeat H1 Revenue Outlook – But Retail Shrugs It Off

The company reported earnings of $0.22 per share compared with a loss of $0.26 per share in the corresponding period of 2023, owing to the launch of its lead product, DefenCath.

CRMD : 12.28 (+5.05%)
VTI : 292.58 (+0.68%)
IWM : 209.85 (+0.83%)
CorMedix: Q4 Earnings Snapshot

CorMedix: Q4 Earnings Snapshot

CRMD : 12.28 (+5.05%)

Business Summary

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company is focused on developing its lead product Defencath (TM), a novel, antibacterial and antifungal solution designed...

See More

Key Turning Points

3rd Resistance Point 13.20
2nd Resistance Point 12.77
1st Resistance Point 12.52
Last Price 12.28
1st Support Level 11.84
2nd Support Level 11.41
3rd Support Level 11.16

See More

52-Week High 13.85
Last Price 12.28
Fibonacci 61.8% 9.94
Fibonacci 50% 8.73
Fibonacci 38.2% 7.52
52-Week Low 3.61

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar